Skip to main content
Tessa NewsLink
Paste a health news link, or browse
Latest checks

Source study found

Story checked

Alcohol use held steady among cancer survivors (opens in a new tab)

medicalxpress.com · 2026-10-30

Short answerEvidenceSource

Short answer

Mixed

Mixed.

The claims we could check match the study, but some claims were not covered by the evidence reviewed.

  • 4 supported
  • 2 not covered

Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.

Share this check

Follow the evidence trail
1
2

NewsLink checks it

Mixed

Every claim we could check holds up. Four of six claims match the study. This overall rating is based only on the claims we could check. Two claims the study doesn't address.

  • 4 supported
  • 2 not covered
Open claim evidence
3
Source paper

Source layer

The 2 papers the story cites

Source study separated from background citations.

The research anchor for the report.

Then inspect each claim

Evidence layer

Claim by claim

Each claim gets a verdict. Expand it to see the evidence directly below.

6 claims in this story

Showing all 6 claimsChoose a verdict to focus the list.

Claim 1 of 6Not coveredThe researchers noted that some people may reduce their alcohol use following a diagnosis or during cancer treatment, although the study could not directly determine whether individuals changed their drinking after diagnosis.View evidenceHide evidence

Why this verdict

The abstract-level profile supports the limitation that the cross-sectional BRFSS design cannot establish temporality or determine individual-level post-diagnosis changes. However, the profile does not verify that the researchers specifically noted that some people may reduce alcohol use after diagnosis or during treatment; that interpretive statement may be in the full paper but is not verifiable from the supplied abstract-depth evidence.

1

Study evidence

Current (past-30-day) drinking prevalence was lower among individuals with a reported cancer history compared with those without across the study years.

“We used Behavioral Risk Factor Surveillance System (BRFSS) cross-sectional data from 2016-2024 for trend”
2

Study evidence

The adjusted prevalence of current drinking was lower among adults with a cancer history compared with those without (BRFSS 2022–2024).

“...and 2022-2024 for prevalence difference analyses.”
Claim 2 of 6Not coveredThe researchers said health care providers have an opportunity to talk with patients about alcohol use and its link to cancer risk.View evidenceHide evidence

Why this verdict

The profile supports the background point that alcohol consumption is a risk factor for several cancer types. But the quoted provider-facing recommendation—health care providers have an opportunity to talk with patients about alcohol use and cancer risk—is not present in the abstract-level profile, so the claim that the researchers said this is not verifiable at this depth.

1

Study evidence

Current (past-30-day) drinking prevalence was lower among individuals with a reported cancer history compared with those without across the study years.

“We used Behavioral Risk Factor Surveillance System (BRFSS) cross-sectional data from 2016-2024 for trend”
Claim 3 of 6SupportedThe drinking rate of adults who have had cancer has remained unchanged for nearly a decade, according to a new study by researchers at the WashU Brown School.View evidenceHide evidence

As statednearly a decade

Why this verdict

The abstract-level profile reports that among adults with a cancer history, current past-30-day drinking was 45.8% in both 2016 and 2024, with APPC = 0.06% and p = .70, indicating no significant trend over the 2016–2024 period. The headline framing is consistent with the body and with the abstract evidence.

1

Study evidence

Current (past-30-day) drinking prevalence was lower among individuals with a reported cancer history compared with those without across the study years.

“We used Behavioral Risk Factor Surveillance System (BRFSS) cross-sectional data from 2016-2024 for trend”
Claim 4 of 6SupportedThe study analyzed nationally representative data from nearly 4 million U.S. adults collected between 2016 and 2024 and compared current alcohol use among adults with and without a reported cancer history.View evidenceHide evidence

As statednearly 4 million U.S. adults; 2016 to 2024

Why this verdict

The profile states that the trend analysis used BRFSS nationally representative repeated cross-sectional data from 2016–2024 with 3,968,799 respondents and compared current past-30-day drinking by self-reported cancer history versus no cancer history.

1

Study evidence

Current (past-30-day) drinking prevalence was lower among individuals with a reported cancer history compared with those without across the study years.

“We used Behavioral Risk Factor Surveillance System (BRFSS) cross-sectional data from 2016-2024 for trend”
Claim 5 of 6SupportedAmong adults without a history of cancer, the percentage reporting alcohol use in the previous 30 days declined from 53.9% in 2016 to 51.5% in 2024.View evidenceHide evidence

As stated53.9% to 51.5%

Why this verdict

The stated values match the paper profile: among individuals without a cancer history, current drinking declined from 53.9% in 2016 to 51.5% in 2024, with APPC = -0.28% and p < .05.

1

Study evidence

Current (past-30-day) drinking prevalence was lower among individuals with a reported cancer history compared with those without across the study years.

“We used Behavioral Risk Factor Surveillance System (BRFSS) cross-sectional data from 2016-2024 for trend”
Claim 6 of 6SupportedAmong adults with a cancer history, the percentage reporting alcohol use remained relatively steady at 45.8% in both 2016 and 2024, and researchers also found lower percentages of binge drinking among adults who have had cancer.View evidenceHide evidence

As stated45.8% in both 2016 and 2024

Why this verdict

The profile supports both parts: current drinking among adults with a cancer history was 45.8% in both 2016 and 2024 with no significant trend, and the adjusted prevalence of binge drinking was lower among those with a cancer history. The binge-drinking finding in the profile specifically comes from adjusted 2022–2024 prevalence-difference analyses, a nuance the story does not spell out.

1

Study evidence

Current (past-30-day) drinking prevalence was lower among individuals with a reported cancer history compared with those without across the study years.

“We used Behavioral Risk Factor Surveillance System (BRFSS) cross-sectional data from 2016-2024 for trend”
2

Study evidence

The adjusted prevalence of current drinking was lower among adults with a cancer history compared with those without (BRFSS 2022–2024).

“...and 2022-2024 for prevalence difference analyses.”
Then look for missing context

Context layer

What the story left out

Important study details the story did not include.

  • By cancer type, adjusted current-drinking prevalence was lower for most cancer sites, except testicular cancer, skin cancer, and melanoma.

    The story does not discuss cancer-type-specific analyses or the exceptions identified in the abstract-level profile.

    From Cross-sectional survey analysis (BRFSS), adjusted prevalence differences (2022–2024)

  • Alcohol use and cancer history were self-reported in BRFSS, creating potential reporting or misclassification bias.

    The story says cancer history was reported but does not mention self-report bias or possible misclassification of either alcohol use or cancer history.

    From Cross-sectional survey analysis (BRFSS), adjusted prevalence differences (2022–2024)

  • BRFSS excludes institutionalized populations and may not capture all subpopulations.

    This limitation is not mentioned in the story.

    From Cross-sectional survey analysis (BRFSS), adjusted prevalence differences (2022–2024)

6 things the story did carry across
  • The study used nationally representative BRFSS repeated cross-sectional survey data for 2016–2024 trend analyses, with 3,968,799 respondents.
  • Current past-30-day drinking declined among adults without a cancer history from 53.9% in 2016 to 51.5% in 2024.
  • Current past-30-day drinking among adults with a cancer history showed no significant change from 2016 to 2024, with 45.8% reported in both endpoint years.
  • Adjusted prevalence of current and binge drinking was lower among adults with a cancer history in the 2022–2024 prevalence-difference analysis.
  • The cross-sectional design cannot establish temporality or causality and cannot determine whether individuals changed drinking behavior after a cancer diagnosis.
  • Alcohol consumption is a risk factor for several cancer types.
Then read the study layer

Study layer

Study at a glance

Scan the study first. Expand only the parts you want to inspect.

Pieces of work

2

Evidence read

study summary

Lead result

secondary data

1Lead resultsecondary dataQuantify national trends (2016–2024) in recent alcohol consumption (current/past-30-day, binge, heavy) by cancer history (yes vs no) among U.S. adults.Repeated cross-sectional survey analysisExpand

In plain English

Repeated cross-sectional analysis of BRFSS data (2016–2024) estimating weighted annual prevalences and linear-regression annual percentage-point changes (APPCs) for current (past-30-day), binge, and heavy drinking stratified by self-reported cancer history; adjusted prevalence-difference analyses used 2022–2024 data.

Key findings

  • Current (past-30-day) drinking prevalence was lower among individuals with a reported cancer history compared with those without across the study years.
  • Among individuals without a cancer history, current drinking declined from 53.9% in 2016 to 51.5% in 2024 (APPC = -0.28%, p < .05).APPC = -0.28% (p < .05); 2016: 53.9% → 2024: 51.5%
“We used Behavioral Risk Factor Surveillance System (BRFSS) cross-sectional data from 2016-2024 for trend”
2secondary dataEstimate adjusted prevalence differences (2022–2024) in recent alcohol consumption comparing adults with vs without a cancer history overall and by cancer type.Cross-sectional survey analysis (BRFSS), adjusted prevalence differences (2022–2024)Expand

In plain English

Using 2022–2024 BRFSS cross-sectional survey data, the authors estimated adjusted prevalence differences in recent alcohol consumption (current, binge, and heavy drinking outcomes considered) comparing U.S. adults with versus without a self-reported cancer history, overall and by cancer type. Adjusted prevalences of current and binge drinking were reported as lower among those with a cancer history; by cancer site, current drinking prevalences were lower for most sites except testicular, skin, and melanoma.

Key findings

  • The adjusted prevalence of current drinking was lower among adults with a cancer history compared with those without (BRFSS 2022–2024).
  • The adjusted prevalence of binge drinking was lower among adults with a cancer history compared with those without.
“...and 2022-2024 for prevalence difference analyses.”
What this piece can’t prove
  • Cross-sectional BRFSS data—cannot establish temporality or causality.
  • Alcohol consumption and cancer history are self-reported in BRFSS; potential for reporting or misclassification bias.
  • Abstract does not report the covariates used in adjusted models or the numerical adjusted prevalence differences and confidence intervals.
  • BRFSS excludes institutionalized populations and may not capture all subpopulations.
Finally, the search trail

Method layer

NewsLink found the paper. Tessa takes you deeper.

NewsLink checks the story. Tessa is where you inspect the paper, authors, evidence, and research context.

Papers considered

The selected paper, plus nearby candidates.

PubMed, Europe PMC, Crossref · 37 candidate papers

CandidateOpen access

The SPIZ study: rationale and protocol of a randomized controlled trial to optimize interdisciplinary care of patients following cellular therapy through a digitally supported, cross-regional and cross-sectoral care model.

2026 · Europe PMC

Tessa (opens in a new tab)Source (opens in a new tab)

And 31 more candidates considered.